Health startup focused on the vaginal microbiome announces $14M Series A


Evvy, a female-founded startup that focuses on vaginal healthcare, has closed on a $14 million Series A funding round.

The round, led by Left Lane Capital, also includes General Catalyst and Labcorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue, and Amboy Street Ventures.

The funding will be used to scale access to Evvy’s testing and care platform, leverage AI to discover novel molecular signatures for women’s health diagnostics, and validate improved outcomes in fertility…

Previous How much Novan sold its assets for in bankruptcy case
Next Grant Thornton leader: Companies should start planning now for 2025 tax changes